Topical Insulin Eye Drops Accelerate Healing of Refractory Neurotrophic Keratopathy
Background
Neurotrophic keratopathy (NK) is a rare, degenerative corneal disease marked by impaired corneal sensory innervation, leading to persistent epithelial defects and ulcers. Conventional therapies often have limited efficacy, leaving patients vulnerable to severe complications. Insulin has emerged as a promising therapeutic agent due to its critical role in tissue repair and its multi-target, multi-pathway molecular mechanisms, offering a novel approach to address the underlying pathology and promote corneal healing.
Study Design
This review synthesizes the current research status of topical insulin therapy for neurotrophic keratopathy (NK). It evaluates the distinctive mechanism of action and substantial effectiveness of insulin eye drops in promoting corneal healing. The review compiles evidence demonstrating insulin's critical role in corneal tissue repair via multi-target and multi-pathway molecular mechanisms, assessing its impact on refractory neurotrophic epithelial defects and corneal ulcers, as well as its safety profile and ease of preparation.
Results
Extensive research consistently demonstrates that insulin plays a critical role in corneal tissue repair, operating through diverse multi-target and multi-pathway molecular mechanisms. Studies show that topical administration of insulin eye drops significantly accelerates the healing of refractory neurotrophic epithelial defects and corneal ulcers. This therapeutic approach is characterized by its high safety profile, ease of preparation, and remarkable therapeutic outcomes. The review highlights insulin's ability to stimulate epithelial cell proliferation, migration, and differentiation, which are crucial processes for restoring corneal integrity. > Topical insulin eye drops significantly accelerate healing of refractory neurotrophic epithelial defects and corneal ulcers. Furthermore, insulin exhibits anti-inflammatory and neurotrophic effects, supporting nerve regeneration and overall corneal health, making it a valuable and reliable treatment option for patients with refractory corneal diseases.
Key Findings
- Topical insulin eye drops significantly accelerate healing of refractory neurotrophic epithelial defects.
- Insulin promotes corneal tissue repair through multi-target and multi-pathway molecular mechanisms.
- The therapy demonstrates a high safety profile and ease of preparation.
- Insulin eye drops are a valuable option for patients with refractory corneal diseases.
Why It Matters
This review consolidates evidence supporting topical insulin eye drops as a viable and effective treatment option for refractory neurotrophic keratopathy. For clinicians and patients, this means a potentially safer and more accessible alternative to current limited therapies, particularly for persistent epithelial defects. The ease of preparation and high safety profile suggest a straightforward path to clinical adoption, potentially improving patient outcomes significantly. While specific protocols are not detailed, the emphasis on topical administration and efficacy points towards a practical, non-invasive treatment strategy that could be integrated into existing care pathways.
insulin
neurotrophic keratopathy
corneal healing
topical therapy
eye drops
corneal ulcers